Press release from Companies

Published: 2022-05-11 11:19:02

Redsense Medical AB: Redsense to exhibit on the 59[th] ERA-EDTA congress

Redsense Medical announces that the company will exhibit on this year’s ERA-EDTA conference in Paris, May 19-22.

The European Renal Association (ERA) and the European Dialysis and Transplant Association (EDTA) organize the largest annual nephrology congress in Europe. The 59th ERA Congress will be held as a hybrid event in Paris on May 19-22, 2022, and will host thousands of attendees from around the world.

Redsense will have exhibition booth C.430. where they will showcase and promote the Redsense Clamp – the company’s novel Bluetooth-connected accessory to the Redsense Alarm, currently in the final stages of clinical validation and in preparation of market roll-out.

For in-depth information about the ERA-EDTA event, please see the official website:

https://www.era-online.org/en/paris2022/

About the Clamp

By immediately clamping the bloodline to stop blood flow when blood leakage is detected, the Clamp equips the Redsense System with an ability highly sought-after in the market: the power to intervene autonomously, without having to rely on a nurse or caregiver noticing and responding to the alarm, and regardless of the dialysis machine in use. With the Clamp upgrade, Redsense obtains safety features without parallel in the market, ensuring that any incident of venous needle dislodgement is addressed rapidly.

For more information, please contact:

Patrik Byhmer, CEO Redsense Medical AB (publ)

Phone: +46 35 10 60 30

info@redsensemedical.com 

www.redsensemedical.com

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medicalsolves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.

Läs mer hos Cision
Read more about Redsense Medical AB

Subscription